Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.22.1
Accrued Expenses
3 Months Ended
Mar. 31, 2022
Payables And Accruals [Abstract]  
Accrued Expenses

8. Accrued Expenses

Accrued expenses consisted of the following as of March 31, 2022 and December 31, 2021 (in thousands):

 

 

 

March 31, 2022

 

 

December 31, 2021

 

External research and preclinical development

 

 

8,521

 

 

$

8,274

 

Employee compensation and benefits

 

 

3,180

 

 

 

6,344

 

Professional fees

 

 

1,495

 

 

 

953

 

Facilities and other

 

 

53

 

 

 

53

 

Accrued expenses

 

$

13,249

 

 

$

15,624